Eiropas Savienība -
īslandiešu -
EMA (European Medicines Agency)
lumykras
amgen europe bv - sotorasib - krabbamein, lungnakrabbamein - Æxlishemjandi lyf - lumykras as monotherapy is indicated for the treatment of adults with advanced non-small cell lung cancer (nsclc) with kras g12c mutation and who have progressed after at least one prior line of systemic therapy.
Īslande -
īslandiešu -
LYFJASTOFNUN (Icelandic Medicines Agency)
amoxicillin mylan (amoxicillin mylan) tafla 750 mg
viatris limited - amoxicillinum tríhýdrat - tafla - 750 mg
Īslande -
īslandiešu -
LYFJASTOFNUN (Icelandic Medicines Agency)
amoxicillin mylan (amoxicillin mylan) hart hylki 500 mg
viatris limited - amoxicillinum tríhýdrat - hart hylki - 500 mg
Īslande -
īslandiešu -
LYFJASTOFNUN (Icelandic Medicines Agency)
prasugrel krka filmuhúðuð tafla 10 mg
krka, d.d., novo mesto - prasugrelum inn - filmuhúðuð tafla - 10 mg
Īslande -
īslandiešu -
LYFJASTOFNUN (Icelandic Medicines Agency)
amoxin mixtúruduft, dreifa 100 mg/ml
ratiopharm gmbh* - amoxicillinum tríhýdrat - mixtúruduft, dreifa - 100 mg/ml
Īslande -
īslandiešu -
LYFJASTOFNUN (Icelandic Medicines Agency)
omeprazol actavis magasýruþolið hart hylki 40 mg
actavis group ptc ehf. - omeprazolum inn - magasýruþolið hart hylki - 40 mg
Īslande -
īslandiešu -
LYFJASTOFNUN (Icelandic Medicines Agency)
omeprazol actavis magasýruþolið hart hylki 20 mg
actavis group ptc ehf. - omeprazolum inn - magasýruþolið hart hylki - 20 mg
Īslande -
īslandiešu -
LYFJASTOFNUN (Icelandic Medicines Agency)
omeprazol actavis magasýruþolið hart hylki 10 mg
actavis group ptc ehf. - omeprazolum inn - magasýruþolið hart hylki - 10 mg
Īslande -
īslandiešu -
LYFJASTOFNUN (Icelandic Medicines Agency)
amoxin filmuhúðuð tafla 500 mg
ratiopharm gmbh* - amoxicillinum tríhýdrat - filmuhúðuð tafla - 500 mg
Īslande -
īslandiešu -
LYFJASTOFNUN (Icelandic Medicines Agency)
esomeprazol actavis magasýruþolin tafla 40 mg
actavis group ptc ehf. - esomeprazolum magnesíum - magasýruþolin tafla - 40 mg